| Biomarker ID | 476 |
| PMID | 19854473 |
| Year | 2010 |
| Biomarker | GLUT1 |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Increased expression in Biochemical Recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | HR 6.6; (95% CI:1.74-24.7) |
| Effect on Pathways | Pathways Include:- Facilitative sodium-independent glucose transporters,Vitamin C in the brain, Vitamin C (ascorbate) metabolism,Kit receptor transcriptional targets, HIF-2-alpha transcription factor network |
| Experiment | PSA recurrence Vs No PSA recurrence |
| Type of Biomarker | Prognostic |
| Cohort | 71 men who underwent radical prostatectomy were chosen. Out of which 43 had PSA recurrence and 23 did not. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.005 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | Multivariate Analysis |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | SLC2A1 |